IMM 4.41% 35.5¢ immutep limited

Ann: GMP Manufacturing Process Developed for IMP761 LAG-3 Agonist, page-6

  1. 777 Posts.
    lightbulb Created with Sketch. 541
    Ahay I am very encouraged by this announcement despite the poor market response. I am very hopeful of a trail starting as quickly as possible.

    I am not sure what the trial will involve and how long it will take to run, but I invite speculation. Is it as challenging and as long as a cancer treatment trial, or could this advance more quickly from Phase 1 to 2 and then 3?

    I assume safety is likely to be low risk, and QOL and blood work can reveal efficacy relatively quickly …. Am I being naive?

    Thanks QQ
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.015(4.41%)
Mkt cap ! $515.6M
Open High Low Value Volume
34.0¢ 36.0¢ 34.0¢ $1.270M 3.611M

Buyers (Bids)

No. Vol. Price($)
7 286261 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 253490 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.